(Bloomberg) -- Leerink Partners, the health-care advisory firm, has continued a recent recruitment drive with hires from boutiques Guggenheim Securities and Gordon Dyal & Co., people with knowledge of the matter said.
Jason Truman and Grant Curry will join Leerink as senior managing directors, the people said, asking not to be identified discussing confidential information.
Health-care specialist Truman joins from Guggenheim, where he has worked for more than five years, according to his LinkedIn profile. Curry has spent almost nine years at Gordon Dyal, advising on deals involving the likes of Novartis AG, Bristol-Myers Squibb Co. and Amgen Inc., his LinkedIn profile shows.
Representatives for Leerink and Guggenheim declined to comment. A spokesperson for Gordon Dyal couldn’t immediately be reached for comment.
Jeff Leerink founded Leerink in 1995 as a health-care and life sciences-focused advisory firm before selling it to SVB Financial Group in 2019. He and his management team bought the investment bank back from the bankrupt former owner of Silicon Valley Bank last year.
Leerink has in recent months added bankers including PJT Partners Inc.’s Tom Davidson, Timothy Hotchandani from Rothschild & Co. and Bernhard Sakmann and Justin Reed from Evercore Inc.
©2024 Bloomberg L.P.